IFNG and neoplasm: For example, RSL-3, a ferroptosis inducer, has been shown to increase the immunogenicity of tumor cells, resulting in an increased infiltration of interferon (IFN)-γ+ T lymphocytes within the tumor and consequently improving immunotherapy [22,23].